NCT03521687View on ClinicalTrials.gov

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

February 12, 2021

Study Completion Date

February 12, 2021

Conditions
Central Centrifugal Cicatricial Alopecia
Interventions
DRUG

Apremilast

30 mg BID

Trial Locations (1)

10023

Mount Sinai West Dermatology, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03521687 - Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA) | Biotech Hunter | Biotech Hunter